Healthstream (HSTM) Liabilities and Shareholders Equity (2016 - 2025)
Healthstream (HSTM) has disclosed Liabilities and Shareholders Equity for 16 consecutive years, with $520.4 million as the latest value for Q4 2025.
- On a quarterly basis, Liabilities and Shareholders Equity rose 1.88% to $520.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.0 billion, a 0.97% increase, with the full-year FY2025 number at $520.4 million, up 1.88% from a year prior.
- Liabilities and Shareholders Equity was $520.4 million for Q4 2025 at Healthstream, up from $499.9 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $524.0 million in Q1 2025 to a low of $477.7 million in Q2 2022.
- A 5-year average of $499.2 million and a median of $499.7 million in 2024 define the central range for Liabilities and Shareholders Equity.
- Peak YoY movement for Liabilities and Shareholders Equity: grew 4.19% in 2021, then fell 3.75% in 2022.
- Healthstream's Liabilities and Shareholders Equity stood at $486.8 million in 2021, then grew by 2.26% to $497.7 million in 2022, then rose by 0.44% to $499.9 million in 2023, then grew by 2.17% to $510.8 million in 2024, then increased by 1.88% to $520.4 million in 2025.
- Per Business Quant, the three most recent readings for HSTM's Liabilities and Shareholders Equity are $520.4 million (Q4 2025), $499.9 million (Q3 2025), and $500.1 million (Q2 2025).